Fernando Campos, n/a

Medical Oncologist
A.C.Camargo Cancer Center, Brazil

Poster(s):

• (P 128) ISOCITRATE DEHYDROGENASE 1 (IDH1) MUTATION TESTING IN THE PHASE 3 STUDY OF IVOSIDENIB VS PLACEBO IN IDH1-MUTANT CONVENTIONAL CHONDROSARCOMA (CHONQUER)

• (P 132) MOLECULAR LANDSCAPE AND CLINICAL HETEROGENEITY OF BRAZILIAN CHONDROSARCOMAS: INSIGHTS FROM IDH, TERT, AND GENOME-WIDE ANALYSIS

• (P 137) GENOMIC ALTERATIONS IN RARE CARTILAGINOUS TUMOR SYNDROMES ASSOCIATED WITH CHONDROSARCOMA DEVELOPMENT

• (P 155) BRCA2-MUTATED CONVENTIONAL CHONDROSARCOMA RESPONDING TO PARP INHIBITION: A CASE REPORT

• (P 278) NEOADJUVANT HYPOFRACTIONATED RADIOTHERAPY AND CHEMOTHERAPY IN EXTREMITY SOFT TISSUE SARCOMAS